intoDNA is a biotech startup founded in 2017, based in Poland. The company's slogan "Where DNA Breaks, Our Insight Begins" embodies its mission to revolutionize DNA break detection. intoDNA offers an end-to-end process for this with its proprietary technology, STRIDE. This innovative tool sets itself apart with its exceptional sensitivity, providing a reliable measure of DNA damage at an individual lesion level.
STRIDE has gained traction in the biotechnology, pharmaceutical, and academic sectors, where it has been utilized by leaders in DNA damage response, cancer immunotherapy, and nuclear medicine. Despite intoDNA not disclosing its latest investment details, the company's growth potential is underscored by its pioneering technology and its resonance within key industry segments.